Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today…
Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today…
Athletes hail Para integration at Nordic World Ski Championships Trondheim 2025, but hint at room for improvement
Apr 01, 2025 - One of the highlights of the FIS Nordic…
EDGNEX Data Centers by DAMAC Confirms Strategic Partnership with Nordic Data Center Developer Hyperco
New acquisition in Nordics is part of the company's ambitious European and global…
More races, more excitement for Nordic Combined fans at Trondheim 2025 WSC
Mar 18, 2025 - Among the success stories of the Trondheim 2025…
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old,…
Bavarian Nordic Completion of Share Buy-Back Program
COPENHAGEN, Denmark, January 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces…
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) has…
Bavarian Nordic Announces Interim Results for the First Nine Months of 2024
COPENHAGEN, Denmark, November 15, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced…
Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases
HERLEV, Denmark, Nov. 11, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company,…
